Clinical Trials Directory

Trials / Completed

CompletedNCT00623207

Use of Atropine in Tredmill Stress Testing

Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
103 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity. Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.

Conditions

Interventions

TypeNameDescription
DRUGAtropineI.V Atropine 0.5mg up to 2 mg

Timeline

Start date
2007-12-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2008-02-25
Last updated
2015-07-27

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00623207. Inclusion in this directory is not an endorsement.

Use of Atropine in Tredmill Stress Testing (NCT00623207) · Clinical Trials Directory